<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1710222741
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CARDEX
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BISOPROLOL FUMARATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        13.35
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="TABUK PHARMACEUTICAL MANUFACTURING CO." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            TABUK PHARMACEUTICAL MANUFACTURING CO.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ACINO PHARMA AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07AB07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active ingredient in this medicine is Bisoprolol fumarate. Cardex<br />belongs to group of medicines called beta-blockers. Beta-blockers protect<br />the heart against too much activity.<br />Cardex 2.5 mg, 5 mg and 10 mg tablets are used in combination with<br />other medicines to treat stable heart failure. Heart failure occurs when the<br />heart muscle is too weak to pump blood around the circulation adequately.<br />This results in breathlessness and swelling.<br />Cardex slows down the heart rate and makes the heart more efficient at<br />pumping blood around the body.<br />Cardex 5 mg and 10 mg tablets are also used to treat high blood pressure<br />(Hypertension) and angina pectoris (Chest pain caused by blockages in the<br />arteries that supply the heart muscle).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Cardex<br />- If you are allergic (Hypersensitive) to Bisoprolol fumarate or any of the<br />other ingredients of Cardex tablets.<br />- If you have severe asthma or sever chronic lung disease.<br />- If you have severe blood circulation problem in your limbs (such as<br />Raynaud&rsquo;s syndrome), which may cause your fingers and toes to tingle<br />or turn pale or blue.<br />- If you have untreated phaeochromocytoma, a rare tumour of the adrenal<br />gland (medulla).<br />- If you have metabolic acidosis, a condition when there is too much acid<br />in the blood.<br />- If you have heart failure that suddenly becomes worse and/or that may<br />require hospital treatment.<br />- If you have slow heart rate.<br />- If you have very low bloodpressure.<br />- If you have a slow or irregular heart rate (less than 60 beats per minute).<br />Ask your doctor if you are notsure.<br />Take special care with Cardex<br />Tell your doctor before you start to take this medicine:<br />- If you have asthma or chronic lung disease.<br />- If you have diabetes. Cardex can hide the symptoms of low blood sugar.<br />- If you are fasting from solid food.<br />- If you are treated for hypersensitivity (allergic) reactions. Cardex may<br />make your allergy worse or more difficult to treat.<br />- If you have any heart problems.<br />- If you have any liver or kidney problems.<br />- If you have any problems with the circulation in your limbs.<br />- If you are going to be given a general anaesthetic during an operation<br />- tell your doctor that you are taking Cardex.<br />- If you are taking verapamil or diltiazem, medicines used to treat heart<br />conditions. Concomitant use is not recommended.<br />- If you have (or have had) psoriasis (a recurring skin rash).<br />- If you have phaeochromocytoma (a rare tumour of the adrenal gland).<br />Your doctor will need to treat this before prescribing Cardex for you.<br />- If you have a thyroid problem. The tablets can hide symptoms of an<br />overactive thyroid.<br />Taking other medicines:<br />Tell your doctor if you are already taking or using any of the following as<br />they may interact with your medicine:<br />- Medicines for controlling the blood pressure or medicines for heart<br />problems (such as amiodarone, amlodipine, clonidine, digitalis glycosides,<br />diltiazem, disopyramide, felodipine, flecainide, lidocaine, methyldopa,<br />moxonidine, phenytoin, propafenone, quinidine, rilmenidine,<br />verapamil).<br />- Medicines for depression e.g. imipramine, amitriptyline, moclobemide.<br />- Medicines to treat mental illness e.g. phenothiazines such as levomepromazine.<br />- Medicines used for anaesthesia during an operation.<br />- Medicines used to treat epilepsy e.g. barbiturates such as phenobarbital.<br />- Certain pain killers (for instance acetyl salicylic acid, diclofenac, indomethacin,<br />ibuprofen, naproxen).<br />- Medicines for asthma or medicines used for a blocked nose.<br />- Medicines used for certain eye disorders such as glaucoma (increased<br />pressure in the eye) or used to widen the pupil of the eye.<br />- Certain medicines to treat clinical shock (e.g. adrenaline, dobutamine,<br />noradrenaline).<br />- Mefloquine, a medicine for malaria.<br />- All these drugs as well as Cardex may influence the blood pressure<br />and/or heart function.<br />- Rifampicin for the treatment ofinfections.<br />- Medicines to treat severe headaches or migraines (ergotamine derivatives).<br />Please tell your doctor or pharmacist if you are taking or have recently<br />taken any other medicines, including medicines obtained without prescription.<br />Pregnancy and breast-feeding:<br />There is a risk that Cardex can harm the baby if it is used during pregnancy.<br />If you are pregnant or plan to become pregnant you should tell your doctor.<br />He or she will determine whether you can take Cardex during pregnancy.<br />It is not known whether bisoprolol fumarate passes in to breast milk.<br />Therefore, breastfeeding is not recommended during treatment with<br />Cardex.<br />Driving and using machine:<br />The ability to drive or operate machinery may be affected, depending on<br />how well you tolerate the medicine. Be especially careful at the beginning<br />of the treatment, when the dose is increased or when the medication is<br />changed, and when combined withalcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Cardex exactly as your doctor has told you. You should check<br />with your doctor or your pharmacist if you are not sure.<br />Treatment with Cardex requires regular medical check up. This is particularly<br />important in the initiation of therapy and during dose increase.<br />Cardex should be taken in the morning, with or without food. Swallow the<br />tablet/s whole with some water and do not chew or crush them. Treatment<br />with Cardex is usually prolonged.<br />Adults:<br />Chest pain and high blood pressure:<br />Your doctor will start the treatment with lowest possible dose (5 mg). Your<br />doctor will monitor you closely at the start of treatment. Your doctor will<br />increase your dose to obtain the best possible dosage for you. The maximum<br />recommended dose is 20 mg once per day.<br />Patient with kidney disease:<br />Patient with severe kidney disease should not exceed 10 mg of bisoprolol<br />once daily. Please consult your doctor before starting to use this medicine.<br />Patient with liver disease:<br />Patient with severe liver disease should not exceed 10 mg of bisoprolol<br />once daily. Please consult your doctor before starting to use this medicine.<br />Heart failure:<br />Before you start using Cardex, you should already be taking other medicines<br />for heart failure including any ACE inhibitor, a diuretic and (as an<br />added option) a cardiac glycoside.<br />Treatment with Cardex must be started at a low dose and increased gradually.<br />Your doctor will decide how to increase the dose, and this will normally be<br />done in the following way:<br />- 1.25 mg bisoprolol fumarate once daily for a week.<br />- 2.5 mg bisoprolol fumarate once daily for a week.<br />- 3.75 mg bisoprolol fumarate once daily for a week.<br />- 5 mg bisoprolol fumarate once daily for four weeks.<br />- 7.5 mg bisoprolol fumarate once daily for four weeks.<br />- 10 mg bisoprolol fumarate once daily for maintenance (on-going)<br />therapy.<br />The maximum recommended daily dose of bisoprolol fumarate is 10 mg.<br />Depending on how well you tolerate the medicine, the doctor may also<br />extend the time between dose increases. If your condition gets worse or if<br />you no longer tolerate the drug, it may be necessary to lower the dose<br />again or to stop treatment. For some patients a maintenance dose lower<br />than 10 mg bisoprolol fumarate may be sufficient. Your doctor will tell you<br />what to do. If you have to stop the treatment entirely, your doctor will<br />usually advice you to reduce the dose gradually, as otherwise your condition<br />may becomeworse.<br />Children:<br />Cardex is not recommended for use in children.<br />Elderly patient:<br />In general adjustment of the dose is not needed. It is recommended to start<br />with lowest possible dose.<br />If you notice that the Cardex dose is too strong or does not work well<br />enough, please consult your doctor or pharmacist.<br />If you take more Cardex than you should<br />If you take too much medicine, or if a child has swallowed the medicine by<br />mistake ask your doctor or hospital for assessing risk and advice. Take this<br />leaflet and any tablets you still have with you. You may feel slow heartbeat,<br />severe breathing difficulties, dizziness or tremor (due to decreased blood<br />sugar).<br />If you forget to take Cardex<br />If you forget to take a dose, take it as soon as you remember it unless it is<br />nearly time for your next dose. Do not take a double dose to make up for a<br />forgotten dose.<br />If you stop taking Cardex<br />Do not stop treatment suddenly or change the recommended dose without<br />talking to your doctor first. If you need to stop treatment, it must be done<br />gradually to avoid side effects.<br />If you have any further question on the use of this product, ask your<br />doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Cardex can cause side effects, although not everybody<br />gets them.<br />The following side effects are important and will require immediate action<br />if you experience them. You should stop taking Cardex and see your doctor<br />immediately if the following symptoms occur:<br />Common side effects (affecting fewer than 1 in 10 people):<br />- Worsening of heart failure causing increased breathlessness and/or<br />retention of fluid.<br />Frequency not stated:<br />- Worsening of symptoms of blockage of the main blood vessels to the<br />legs, especially at the start of treatment.<br />The following side effects have also been reported:<br />Very common side effects (affecting more than 1 in 10 people):<br />- Slow heart beat.<br />Common side effects (affecting fewer than 1 in 10 people):<br />- Cold hands and/or feet.<br />- Numbness of hands and/orfeet.<br />- Low bloodpressure.<br />- Feeling sick, vomiting, diarrhoea, constipation.<br />- Tiredness*.<br />- Feeling weak.<br />- Dizziness*.<br />- Headache*.<br />Uncommon side effects (affecting fewer than 1 in 100 people):<br />- Worsening of irregular heart beat.<br />- Sleep disorders.<br />- Depression.<br />- Breathing problems in patients with asthma or chronic lung disease.<br />- Muscle weakness, muscle cramps.<br />Rare side effects (affecting fewer than 1 in 1,000 people):<br />- Changes in blood test results.<br />- Reduced tear flow (can be a problem if you wear contact lenses).<br />- Hearingdisorders.<br />- Blocked, runny nose.<br />- Inflammation of the liver (hepatitis) causing abdominal pain, loss of<br />appetite and sometimes jaundice with yellowing of the whites of the<br />eyes and skin and darkurine.<br />- Hypersensitivity reactions such as itching, redness and skin rash.<br />- Reduced sexualperformance.<br />- Nightmares.<br />- Hallucinations (imagining things).<br />- Fainting.<br />Very rare side effects (affecting fewer than 1 in 10,000 people):<br />- Inflammation of the eye (conjunctivitis).<br />- Aggravation of the skin condition psoriasis or the appearance of a<br />similar dry, scaly rash.<br />- Hair loss.<br />* If treated for high blood pressure or angina then these symptoms occur<br />especially at the beginning of treatment, or if your dosage changes.<br />They are generally mild and often disappear within 1 to 2 weeks.<br />If any of the side effects get serious or if any side effect is noticed which is<br />not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of reach of children.<br />Store below 30&deg; C.<br />Do not use beyond the expiry date or if the product shows any sign of<br />deterioration.<br />Do not throw away any medicines via wastewater or household waste. Ask<br />your pharmacist how to throw away the medicines you no longer use.<br />These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Cardex 2.5 mg: Each film coated tablet contains: Bisoprolol Fumarate<br />2.5 mg.<br />Cardex 5 mg: Each film coated tablet contains: Bisoprolol Fumarate 5 mg.<br />Cardex 10 mg: Each film coated tablet contains: Bisoprolol Fumarate<br />10 mg.<br />Excipients: Cellulose microcrystalline, starch, colloidal silicone dioxide,<br />talc, magnesium stearate, HPMC, PEG, titanium dioxide, ferric oxide yellow,<br />and simethicone.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Packs of 30 Film Coated Tablets.
Hospital packs are available.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Tabuk Pharmaceutical Manufacturing Company<br />Madina Road, P.O. Box 3633, Tabuk, Saudi Arabia.<br />Marketing Authorisation Holder:<br />Acino Pharma AG, Birsweg 2, 4253 Liesberg, Switzerland.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Revision date: June 2014.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>المادة الفعالة في هذا الدواء هي بيسوبرولول فيومارات، ينتمي كاردكس إلى مجموعة من الأدوية تعرف<br />بحاصرات بيتا. تمنع حاصرات بيتا فرط نشاط عضلة القلب.<br />تستعمل أقراص كاردكس 2,5 ملجم، 5 ملجم، 10 ملجم بالتزامن مع الأدوية الأخرى لعلاج الحالة<br />المستقرة من قصور عضلة القلب. يحدث قصور عضلة القلب عندما تكون عضلة القلب غير قادرة على<br />ضخ الدم في جميع أنحاء الجسم بشكل كافٍ، مما يؤدي إلى ضيق النفس والتورُّم.<br />يبطء كاردكس من معدل نبضات القلب ويجعل عضلة القب أكثر فعالية في ضخّ الدم حول الجسم.<br />تستعمل أقراص كاردكس 5 ملجم و 10 ملجم أيضاً لعلاج ارتفاع ضغط الدم والذبحة الصدرية<br />)ألم الصدر الناتج عن انسداد الشرايين التي تغذي عضلة القلب(.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>موانع استعمال كاردكس<br />- إذا كنت تعاني من الحساسية )فرط الحساسية( لبيسوبرولول فيومارات أو لأي مكونات أخرى في<br />أقراص كاردكس.<br />- إذا كنت تعاني من الربو الحاد أو أمراض الرئة المزمنة الحادة.<br />- إذا كنت تعاني من مشكلة حادة في دوران الدم في الأطراف )مثل متلازمة رينود(، التي تسبب<br />الإحساس بوخز خفيف في أصابع اليدين والقدمين أو تغير لونهم إلى اللون الشاحب أو الأزرق.<br />- إذا كنت تعاني من ورم القواتم غير المعالج، مرض نادر يصيب الغدة الكظرية )نخاع العظم(.<br />- إذا كنت تعاني من الحماض الأيضي، حالة تظهر عند زيادة مستوى الحمض في الدم.<br />- إذا كنت تعاني من قصور عضلة القلب الذي يسوء فجأة و/ أو الذي قد يتطلب العلاج<br />في المستشفى.<br />- بطء سرعة نبضات اللقلب.<br />- انخفاض شديد في ضغط الدم.<br />- إذا كنت تعاني من بطء السرعة أو عدم انتظام نبضات القلب )أقل من 60 نبضة/ دقيقة(، استشر<br />طبيبك إذا لم تكن متأكداً.<br />الاحتياطات عند تناول كاردكس<br />أخبر طبيبك قبل البدء بتناول هذا الدواء:<br />- إذا كنت تعاني من الربو أو أمراض الرئة المدمنة.<br />- إذا كنت تعاني من داء السكري، قد يخفي كاردكس أعراض انخفاض مستوى سكر الدم.<br />- إذا كنت تتبع حمية غذائية تمنع تناول الأطعمة الصلبة.<br />- إذا كنت تخضع لعلاج تفاعلات فرط الحساسية )التحسُّس(، حيث قد يؤدي كاردكس لزيادة أعراض<br />التحسُّس سوءاً، أو جعل علاجها أكثر صعوبة.<br />- إذا كنت تعاني من أي مشاكل قلبية.<br />- إذا كنت تعاني من أي مشاكل في الكبد أو الكلى.<br />- إذا كنت تعاني من أي مشاكل في جهاز الدوران في الأطراف.<br />- إذا كنت ستخضع للتخدير العام خلال إجراء عملية جراحية- أخبر طبيبك أنك تتناول كاردكس.<br />- إذا كنت تتناول فيراباميل أو ديلتيازم، أدوية تستعمل لعلاج الحالات القلبية، لا يوصى<br />بالإستعمال المتزامن.<br />- إذا كنت تعاني )أو عانيت( في السابق من الصدفية )طفح جلدي متكرر(.<br />- إذا كنت تعاني من ورم القواتم، )ورم نادر صيب الغدة الكظرية(. قد يحتاج طبيبك لعلاج هذه<br />الحالة قبل وصف كاردكس لك.<br />- إذا كنت تعاني من مشكلة في الغدة الدرقية. قد تخفي أقراص كاردكس أعراض فرط نشاط<br />الغدة الدرقية.<br />تناول أدوية أخرى:<br />أخبر طبيبك إذا كنت تتناول حالياً أو تستعمل أي من الأدوية التالية لأنها قد تؤثر على فعالية هذا الدواء:<br />- الأدوية المستعملة للسيطرة على ضغط الدم أو الأدوية المستعملة لعلاج مشاكل القلب )مثل<br />أميودارون، أملوديبين، كلونيدين، الجلايكوسيدات القلبية، ديلتيازيم، ديسوبيراميد، فيلوديبين،<br />فليكينايد، ليدوكائين، ميثيل دوبا، موكسونيدين، فينتوين، بروبافينون، كوينيدين، ريلمينيدين،<br />فيراباميل(.<br />- الأدوية المضادة للاكتئاب مثل إيميبرامين، أميتريبتيلين، موكلوبيمايد.<br />- ادوية المستعملة لعلاج الأمراض العقلية مثل مجموعة الفينوثيازين مثل ليفوميبرومازين.<br />- الأدوية المستعملة للتخدير خلال العمليات الجراحية.<br />- الأدوية المستعملة لعلاج الصرع مثل مجموعة الباربيتيورات مثل الفينوباربيتال.<br />- بعض مسكنات الألم )مثل حمض الأسيتايل ساليساليك، ديكلوفيناك، إندوميثاسين، أيبوبروفين<br />ونابروكسين(.<br />- الأدوية المستعملة علاج الربو أو الأدوية المستعملة لعلاج احتقان الأنف.<br />- الأدوية المستعملة لعلاج بعض اضطرابات العين مثل الجلوكوما )زيادة الضغط في العين( أو الأدوية<br />المستعملة لتوسيع بؤبؤ العين.<br />- بعض الأدوية المستعملة لعلاج الصدمات السريرية )مثل أدرينالين، دوبيوتامين، ونورادرينالين(.<br />- مفلوكين، دواء لعلاج الملاريا.<br />- جميع الأدوية وكذلك كاردكس قد تؤثر على ضغط الدم و/ أو وظيفة عضلة القلب.<br />- ريفامبيسين، دواء لعلاج الالتهابات.<br />- الأدوية المستعملة لعلاج الصداع الشديد أو الشقيقة )مشتقات ايرجوتامين(.<br />الرجاء أن تخبر طبيبك أو الصيدلاني إذا كنت تتناول أو تناولت مؤخراً أي أدوية أخرى.<br />بما في ذلك الأدوية التي يتم الحصول عليها بدون وصفة طبية.<br />الحمل والإرضاع:<br />من الممكن أن يؤدي استعمال كاردكس خلال فترة الحمل إلى إيذاء الجنين. يجب أن تخبري طبيبك إذا<br />كنت حامل أو تخططين لذلك.<br />سيقرر هو/ هي إذا كان من الممكن تناول كاردكس خلال فترة الحمل.<br />من غيرالمعروف إذا كان بيسوبرولول فيومارات يفرز في حليب الثدي.<br />لذلك لا يوصى بالإرضاع خلال فترة العلاج بكاردكس.<br />قيادة المركبات واستخدام الآلات:<br />قد تتأثر قدرتك على قيادة أو تشغيل الآلات اعتماداً على قدرة تحملك للدواء. يجب أخذ الحيطة بشكل<br />خاص عند بداية العلاج، عند زيادة الجرعة أو عند تغيير الدواء، وعند تناول الكحول بشكل متزامن</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>دائماً تناول كاردكس تماماً كما أخبرك طبيبك. يجب أن تستشير طبيبك أو الصيدلاني إذا لم تكن متأكداً<br />يتطلب العلاج بكاردكس إجراء فحوصات طبية منتظمة. خصوصاً عند بداية العلاج وخلال زيادة<br />الجرعة. يجب تناول كاردكس في الصباح، مع أو دون تناول الطعام.<br />ابلع القرص كاملاً مع قليل من الماء، دون مضغها أو كسرها. العلاج بكاردكس عادة يكون طويل الأمد.<br />البالغون:<br />ألم الصدر وارتفاع ضغط الدم:<br />سيبدأ طبيبك العلاج باستعمال أقل جرعة ممكنة ) 5 ملجم(. سوف يراقبك طبيبك عن كثب في بداية<br />العلاج. ثم سيزيد الجرعة للحصول على أفضل جرعة ممكنة بالنسبة لك. الجرعة القصوى الموصى بها<br />هي 20 ملجم مرة واحدة يومياً.<br />المرضى الذين يعانون من مرض في الكلى:<br />يجب أن لا تتجاوز الجرعة عن 10 ملجم يومياً للمرضى الذين يعانون من مرض حاد في الكلى. يرجى<br />استشارة الطبيب قبل البدء في تناول هذا الدواء.<br />المرضى الذين يعانون من مرض في الكبد:<br />يجب أن لا تتجاوز الجرعة عن 10 ملجم يومياً للمرضى الذين يعانون من مرض حاد في الكبد. يرجى<br />استشارة الطبيب قبل البدء في تناول هذا الدواء.<br />قصور عضلة القلب:<br />قبل البدء باستعمال كاردكس، يجب أن تكون قد بدأت مؤخراً بتناول أدوية أخرى لعلاج قصور<br />عضلة القلب بما في ذلك أي مثبطات الإنزيم المحوّل للأنجيوتنسين، مدر البول، والجلايكوسيد القلب ي<br />)كخيار إضافي(.<br />يجب بدء العلاج بكاردكس بجرعة منخفضة ثم زيادتها تدريجياً.<br />سيقرر طبيبك كيفية زيادة الجرعة، ويتم ذلك عادة على النحو التالي:<br />- 1,25 ملجم بيسوبرولول فيومارات مرة واحدة يومياً لمدة أسبوع.<br />- 2,5 ملجم بيسوبرولول فيومارات مرة واحدة يومياً لمدة أسبوع.<br />- 3,75 ملجم بيسوبرولول فيومارات مرة واحدة يومياً لمدة أسبوع.<br />- 5 ملجم بيسوبرولول فيومارات مرة واحدة يومياً لمدة أربعة أسابيع.<br />- 7,5 ملجم بيسوبرولول فيومارات مرة واحدة يومياً لمدة أربعة أسابيع.<br />- 10 ملجم بيسوبرولول فيومارات مرة واحدة يومياً كعلاج محافظ )مستمر(.<br />الجرعة اليومية القصوى الموصى بها من بيسوبرولول فيومارات هي 10 ملجم.<br />اعتماداً على قدرة تحملك للدواء، يمكن للطبيب أيضاً تمديد الوقت بين كل زيادة للجرعة. إذا ازدادت<br />حالتك سوءاً، أو إذا لم تعد تتحمل الدواء، قد يكون من الضروري خفض الجرعة مرة أخرى أو وقف<br />العلاج. بالنسبة لبعض المرضى قد تكون الجرعة المحافظة التي تقل عن 10 ملجم بيسوبرولول فيومارات<br />كافية. سوف يخبرك طبيبك ما يجب القيام به. إذا كان لا بد من وقف العلاج كلياً، عادةً سينصحك<br />طبيبك بخفض الجرعة تدريجياً، وإلا قد تزداد حالتك سوءاً.<br />الأطفال: لا يوصى باستعمال كاردكس للأطفال.<br />المرضى كبار السن: بشكل عام، لا يوجد ضرورة لتعديل الجرعة. يوصى ببدء العلاج بأقل جرعة ممكنة.<br />إذا لاحظت أن مفعول جرعة كاردكس قوي جداً ولا يعمل جيداً بما فيه الكفاية، الرجاء القيام باستشارة<br />الطبيب أو الصيدلاني.<br />إذا تناولت كاردكس أكثر مما يجب<br />إذا تناولت أقراص من هذا الدواء أكثر مما يجب، أو إذا ابتلعها الطفل عن طريق الخطأ، اسأل طبيبك<br />أو المستشفى لتقييم الخطورة وتقديم المشورة. اصطحب معك هذه النشرة وأي أقراص متبقية لديك.<br />قد تشعر بانخفاض سرعة سرعة نبضات القب، صعوبات حادة في التنفس، الشعور بالدوار، أو الرُّعاش<br />)نتيجة لانخفاض مستوى سكر الدم(.<br />إذا نسيت تناول جرعة كاردكس:<br />إذا نسيت تناول الجرعة، تناولها فوراً عندما تتذكر، إلا إذا اقترب موعد الجرعة التالية. لا تتناول جرعة<br />مضاعفة لتعويض الجرعة التي نسيتها.<br />إذا توقفت عن تناول كاردكس:<br />لا تتوقف عن تناول علاجك بشكل مفاجئ، أو تُغير الجرعة الموصى بها دون الرجوع للطبيب أولاً. إذا<br />كنت بحاجة لوقف العلاج، يجب إجراء ذلك بشكل تدريجي لتجنُّب حدوث الآثار الجانبية.<br />إذا كان لديك أي أسئلة إضافية عن استعمال هذا الدواء، اسأل طبيبك أو الصيدلاني.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل كل الأدوية، قد يُسبب كاردكس آثاراً جانبية، على الرغم من عدم حدوثها لدى الجميع.<br />تعتبر الآثار الجانبية التالية مهمة وقد تتطلب إجراء فوري إذا حصلت لديك. يجب التوقف عن تناول<br />كاردكس ومراجعة الطبيب عى الفور إذا حصلت لديك الأعراض التالية:<br />الآثار الجانبية الشائعة )تؤثر على أقل من 1 من كل 10 أشخاص(:<br />- تفاقم حالة قصور عضلة القلب وذلك يؤدي إلى زيادة حالة ضيق النفس و/ أو احتباس السوائل سوءاً.<br />التكرار غير معروف<br />- تفاقم أعراض انسداد الأوعية الدموية الرئيسية في الساقين، خصوصاً في بداية العلاج.<br />سجلت الآثار الجانبية التالية أيضاً:<br />الآثار الجانبية الشائعة جداً )تؤثر على أكثر من 1 من كل 10 أشخاص(:<br />- بطء نبضات القلب.<br />الآثار الجانبية الشائعة )تؤثر على أقل من 1 من كل 10 أشخاص(:<br />- الشعور بالبرودة في الطرفين )اليدين و/ أو القدمين(.<br />- تنمل )خدر( اليدين و/ أو القدمين.<br />- انخفاض ضغط الدم.<br />- الشعور بالغثيان والقيء، إسهال، إمساك.<br />- الشعور بالتعب *.<br />- الشعور بالضعف.<br />- الدوار *.<br />- الصداع *.<br />الآثار الجانبية غير الشائعة )تؤثر على أقل من 1 من كل 100 شخص(:<br />- تفاقم حالة عدم انتظام نبضات القلب.<br />- اضطرابات النوم.<br />- اكتئاب.<br />- مشاكل تنفسية عند المرضى الذين يعانون من الربو أو أمراض الرئة المزمنة.<br />- ضعف وتشنج العضلات.<br />الآثار الجانبية النادرة )تؤثر على أقل من 1 من كل 1000 شخص(:<br />- تغيرات في نتائج فحص الدم.<br />- انخفاض تدفق الدموع )قد تكون مشكلة في حال ارتداء العدسات اللاصقة(.<br />- اضطرابات السمع.<br />- انسداد، سيلان الأنف.<br />- التهاب الكبد، مسبباً ألم في البطن، فقدان الشهية، وأحياناً يرقان، مع اصفرار المنطقة البيضاء في<br />العينين والجلد، والبول الداكن.<br />- تفاعلات فرط الحساسية مثل الحكة، احمرار وطفح الجلد.<br />- انخفاض القدرة الجنسية.<br />- كوابيس.<br />- هلوسات )تخيل الأشياء(.<br />- إغماء.<br />الآثار الجانبية النادرة جداً )تؤثر على أقل من 1 من كل 10000 شخص(:<br />- التهاب في العينين )التهاب الملتحمة(<br />- زيادة حالة المرض الجلدي )الصدفية( سوءاً، أو ظهور طفح جلدي مماثل جاف ومتقشر.<br />- تساقط الشعر<br />* إذا خضعت لعلاج ارتفاع ضغط الدم، أو الذبحة الصدرية، فإن هذه الأعراض قد تحدث فقط<br />عند بدء العلاج، أو إذا تغيرت جرعتك. وعادة ما تكون خفيفة وغالباً ما تختفي خلال أسبوع<br />إلى أسبوعين.<br />إذا ازدادت حدة أي من الآثار الجانبية، أو إذا لاحظت أي آثار حانبية غير مذكورة في هذه النشرة، الرجاء<br />أن تخبر طبيبك أو الصيدلاني.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيداً عن متناول الأطفال.<br />يحفظ في درجة حرارة أقل من 30 &deg;م.<br />لا تستعمل هذا الدواء بعد انتهاء مدة صلاحيته أو عند ملاحظة أي علامة تلف فيه.<br />يجب التخلص من أي أدوية عن طريق رميها في المياه العادمة أو النفايات المنزلية. استشر الصيدلاني<br />عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. سوف تساعد هذه التدابيرفي حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ماذا يحتوي كاردكس:<br />كاردكس 2,5 ملجم: يحتوي كل قرص مغلف على: بيسوبرولول فيومارات 2,5 ملجم<br />كاردكس 5 ملجم: يحتوي كل قرص مغلف على: بيسوبرولول فيومارات 5 ملجم<br />كاردكس 10 ملجم: يحتوي كل قرص مغلف على: بيسوبرولول فيومارات 10 ملجم.<br />السواغات: سيليلوز دقيق البلورات، نشا، ثاني أكسيد السيليكون الغروي، تلك، مغنيسيوم ستياريت،<br />هيدروكسي بروبيل ميثيل سيليلوز، بولي ايثيلين جلايكول، ثاني أكسيد التيتانيوم، أكسيد الحديد<br />الأصفر وسيميثيكون.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>عبوات تحتوي على 30 قرصاً مغلفاً.<br />تتوفر عبوات خاصة بالمستشفيات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>إنتاج:<br />شركة تبوك للصناعات الدوائية.<br />طريق المدينة، ص.ب 3633 ، تبوك- المملكة العربية السعودية.<br />مالك رخصة التسويق:<br />أسينو فارما أ.ج، بيرسوغ 2، 4253 لزبيرغ، سويسرا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تاريخ النشرة الدوائية: حزيران 2014 .
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cardex 5 mg film coated tablet
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film coated tablet contains: Bisoprolol Fumarate 5 mg.
For a full list of excipients see Section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film coated tablet.
Beige colored heart shaped film coated tablets engraved with HU on one side and plain on the
other side with break line on both sides.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of Hypertension<br />Treatment of stable chronic angina<br />Treatment of stable chronic heart failure with reduced systolic left ventricular function in<br />addition to ACE inhibitors, and diuretics, and optionally cardiac glycosides (for<br />additional information see section 5.1)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Administration:<br />For oral use.<br />Cardex tablet should be taken in morning and can be taken with food in morning. They<br />should be swallowed in liquid and should not be chewed.<br />Treatment of hypertension and chronic stable angina pectoris<br />Adults<br />The dosage should be individually adjusted. It is recommended to start with 5 mg per<br />day. The usual dose is 10 mg once daily with a maximum recommended dose of 20 mg<br />per day.<br />Patients with renal impairment<br />In patients with severe renal impairment (creatinine clearance &lt; 20 ml/min) the dose<br />should not exceed 10 mg once daily. This dosage may eventually be divided into halves.<br />Patients with severe liver impairment<br />No dosage adjustment is required, however careful monitoring is advised.<br />Elderly<br />No dosage adjustment is normally required. It is recommended to start with the lowest<br />possible dose.<br />Children<br />There is no experience with bisoprolol in children, therefore its use cannot be<br />recommended for children.<br />Discontinuation of treatment<br />Treatment should not be stopped abruptly (see section 4.4). The dosage should be<br />diminished slowly by a weekly halving of the dose.<br />Treatment of stable chronic heart failure<br />Adults<br />Standard treatment of CHF consists of an ACE inhibitor (or an angiotensin receptor<br />blocker in case of intolerance to ACE inhibitors), a beta-blocker, diuretics, and when<br />appropriate cardiac glycosides. Patients should be stable (without acute failure) when<br />bisoprolol treatment is initiated.<br />It is recommended that the treating physician should be experienced in the management<br />of chronic heart failure.<br />Transient worsening of heart failure, hypotension, or bradycardia may occur during the<br />titration period and thereafter.<br />Titration phase<br />The treatment of stable chronic heart failure with bisoprolol requires a titration phase<br />The treatment with bisoprolol is to be started with a gradual uptitration according to the<br />following steps:<br />- 1.25 mg once daily for 1 week, if well tolerated increase to<br />- 2.5 mg once daily for a further week, if well tolerated increase to<br />- 3.75 mg once daily for a further week, if well tolerated increase to<br />- 5 mg once daily for the 4 following weeks, if well tolerated increase to<br />- 7.5 mg once daily for the 4 following weeks, if well tolerated increase to<br />- 10 mg once daily for the maintenance therapy.<br />The maximum recommended dose is 10 mg once daily.<br />Close monitoring of vital signs (heart rate, blood pressure) and symptoms of worsening<br />heart failure is recommended during the titration phase. Symptoms may already occur<br />within the first day after initiating the therapy.<br />Treatment modification<br />If the maximum recommended dose is not well tolerated, gradual dose reduction may be<br />considered.<br />In case of transient worsening of heart failure, hypotension, or bradycardia<br />reconsideration of the dosage of the concomitant medication is recommended. It may also<br />be necessary to temporarily lower the dose of bisoprolol or to consider discontinuation.<br />The reintroduction and/or uptitration of bisoprolol should always be considered when the<br />patient becomes stable again.<br />If discontinuation is considered, gradual dose decrease is recommended, since abrupt<br />withdrawal may lead to acute deterioration of the patient&#39;s condition.<br />Treatment of stable chronic heart failure with bisoprolol is generally a long-term<br />treatment.<br />Special population<br />Renal or hepatic impairment<br />There is no information regarding pharmacokinetics of bisoprolol in patients with chronic<br />heart failure and with impaired hepatic or renal function. Up titration of the dose in these<br />populations should therefore be made with additional caution.<br />Elderly<br />No dosage adjustment is normally required.<br />Children<br />There is no paediatric experience with bisoprolol, therefore its use cannot be<br />recommended for children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cardex is contraindicated in chronic heart failure patients with:
- acute heart failure or during episodes of heart failure decompensation requiring i.v.
inotropic therapy
- cardiogenic shock
- second or third degree AV block (without a pacemaker)
- sick sinus syndrome
- sinoatrial block
- Symptomatic bradycardia
- Symptomatic hypotension
- severe bronchial asthma or severe chronic obstructive pulmonary disease
- late stages of peripheral arterial occlusive disease and Raynaud's syndrome
- untreated phaeochromocytoma (see section 4.4)
- metabolic acidosis
- hypersensitivity to bisoprolol or to any of the excipients (See section 6.1)
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Special warnings:<br />Applies only to chronic heart failure:<br />The treatment of stable chronic heart failure with bisoprolol has to be initiated with<br />special titration phase (see section 4.2).<br />Applies to all indications:<br />Especially in patients with ischemic heart disease the cessation of therapy with bisoprolol<br />must not be done abruptly unless clearly indicated, because this may lad to transition<br />worsening of heart condition (See section 4.2).<br />Precautions:<br />Applies only to hypertension or angina pectoris:<br />Bisoprolol must be used with caution in patients with hypertension or angina pectoris and<br />accompanying heart failure.<br />Applies only to chronic heart failure:<br />The initiation of treatment with bisoprolol necessitates regular monitoring. For posology<br />and method of administration please (See section 4.2).<br />There is no therapeutic experience of bisoprolol treatment of heart failure in patients with<br />the following diseases and conditions:<br />- insulin dependent diabetes mellitus (type I)<br />- severely impaired renal function<br />- severely impaired hepatic function<br />- restrictive cardiomyopathy<br />- congenital heart disease<br />- haemodynamically significant organic valvular disease<br />- myocardial infarction within 3 months<br />Applies to all indications:<br />Bisoprolol must be used with caution in:<br />- bronchospasm (bronchial asthma, obstructive airways diseases).<br />In bronchial asthma or other chronic obstructive lung diseases, which may cause<br />symptoms, bronchodilating therapy is recommended to be given concomitantly.<br />Occasionally an increase of the airway resistance may occur in patients with asthma,<br />therefore the dose of beta2-stimulants may have to be increased.<br />- diabetes mellitus with large fluctuations in blood glucose values; symptoms of<br />hypoglycaemia (e.g. tachycardia, palpitations or sweating) can be masked.<br />- strict fasting<br />- ongoing desensitisation therapy<br />As with other beta-blockers, bisoprolol may increase both the sensitivity towards<br />allergens and the severity of anaphylactic reactions. Adrenaline treatment does not<br />always give the expected therapeutic effect.<br />- first degree AV block<br />- Prinzmetal&#39;s angina<br />- peripheral arterial occlusive disease (intensification of complaints might happen<br />especially during the start of therapy)<br />- general anaesthesia<br />In patients undergoing general anaesthesia beta-blockade reduces the incidence of<br />arrhythmias and myocardial ischemia during induction and intubation, and the postoperative<br />period. It is currently recommended that maintenance beta-blockade be<br />continued peri-operatively. The anaesthesist must be aware of beta-blockade because of<br />the potential for interactions with other drugs, resulting in bradyarrhythmias, attenuation<br />of the reflex tachycardia and the decreased reflex ability to compensate for blood loss. If<br />it is thought necessary to withdraw beta-blocker therapy before surgery, this should be<br />done gradually and completed about 48 hours before anaesthesia.<br />Patients with psoriasis or with a history of psoriasis should only be given beta-blockers<br />(e.g. bisoprolol) after carefully balancing the benefits against the risks.<br />In patients with phaeochromocytoma bisoprolol must not be administered until after<br />alpha-receptor blockade.<br />Under treatment with bisoprolol the symptoms of a thyrotoxicosis may be masked.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Combinations not recommended<br />Applies only to chronic heart failure:<br /> Class I antiarrhythmic drugs (e.g. quinidine, disopyramide; lidocaine, phenytoin;<br />flecainide, propafenone): Effect on atrio-ventricular conduction time may be potentiated<br />and negative inotropic effect increased.<br />Applies to all indications:<br /> Calcium antagonists of the verapamil type and to a lesser extent of the diltiazem type:<br />Negative influence on contractility and atrio-ventricular conduction. Intravenous<br />administration of verapamil in patients on -blocker treatment may lead to profound<br />hypotension and atrioventricular block.<br /> Centrally acting antihypertensive drugs such as clonidine and others (e.g. methyldopa,<br />moxonodine, rilmenidine): Concomitant use of centrally acting antihypertensive drugs<br />may worsen heart failure by a decrease in the central sympathetic tonus (reduction of<br />heart rate and cardiac output, vasodilation). Abrupt withdrawal, particularly if prior to<br />beta-blocker discontinuation, may increase risk of rebound hypertension.<br />Combinations to be used with caution<br />Applies only to hypertension or angina pectoris:<br />Class-I antiarrhythmic drugs (e.g. quinidine, disopyramide; lidocaine, phenytoin;<br />flecainide propafenone): Effect on atrio-ventricular conduction time may be potentiated<br />and negative inotropic effect increased.<br />Applies to all indications<br /> Calcium antagonists of the dihydropyridine type such as felodipine and amlodipine:<br />Concomitant use may increase the risk of hypotension, and an increase in the risk of a<br />further deterioration of the ventricular pump function in patients with heart failure cannot<br />be excluded.<br /> Class-III antiarrhythmic drugs (e.g. amiodarone): Effect on atrio-ventricular conduction<br />time may be potentiated.<br /> Topical beta-blockers (e.g. eye drops for glaucoma treatment) may add to the systemic<br />effects of bisoprolol.<br /> Parasympathomimetic drugs: Concomitant use may increase atrio-ventricular<br />conduction time and the risk of bradycardia.<br /> Insulin and oral antidiabetic drugs: Increase of blood sugar lowering effect. Blockade of<br />beta-adrenoreceptors may mask symptoms of hypoglycaemia.<br /> Anaesthetic agents: Attenuation of the reflex tachycardia and increase of the risk of<br />hypotension (for further information on general anaesthesia see also section 4.4.).<br /> Digitalis glycosides: Reduction of heart rate, increase of atrio-ventricular conduction<br />time.<br /> Non-steroidal anti-inflammatory drugs (NSAIDs): NSAIDs may reduce the hypotensive<br />effect of bisoprolol.<br /> -Sympathomimetic agents (e.g. isoprenaline, dobutamine): Combination with<br />bisoprolol may reduce the effect of both agents.<br /> Sympathomimetics that activate both - and -adrenoceptors (e.g. noradrenaline,<br />adrenaline): Combination with bisoprolol may unmask the -adrenoceptor-mediated<br />vasoconstrictor effects of these agents leading to blood pressure increase and exacerbated<br />intermittent claudication. Such interactions are considered to be more likely with<br />nonselective -blockers.<br /> Concomitant use with antihypertensive agents as well as with other drugs with blood<br />pressure lowering potential (e.g. tricyclic antidepressants, barbiturates, phenothiazines)<br />may increase the risk of hypotension.<br />Combinations to be considered<br /> Mefloquine: increased risk of bradycardia<br /> Monoamine oxidase inhibitors (except MAO-B inhibitors): Enhanced hypotensive<br />effect of the beta-blockers but also risk for hypertensive crisis.<br /> Rifampicin: Slight reduction of the half-life of bisoprolol due to the induction of hepatic<br />drugmetabolising enzymes. Normally no dosage adjustment is necessary.<br /> Ergotamine derivatives: Exacerbation of peripheral circulatory disturbances.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy Category C<br />Pregnancy:<br />Bisoprolol has pharmacological effects that may cause harmful effects on pregnancy<br />and/or the fetus/newborn. In general, beta-adrenoceptor blockers reduce placental<br />perfusion, which has been associated with growth retardation, intrauterine death, abortion<br />or early labour. Adverse effects (e.g. hypoglycaemia and bradycardia) may occur in the<br />fetus and newborn infant. If treatment with beta-adrenoceptor blockers is necessary,<br />beta1-selective adrenoceptor blockers are preferable.<br />Bisoprolol is not recommended during pregnancy unless clearly necessary. If treatment<br />with bisoprolol is considered necessary, the uteroplacental blood flow and the fetal<br />growth should be monitored. In case of harmful effects on pregnancy or the fetus<br />alternative treatment should be reccomended. The newborn infant must be closely<br />monitored. Symptoms of hypoglycaemia and bradycardia are generally to be expected<br />within the first 3 days.<br />Lactation:<br />There are no data on the excretion of bisoprolol excreted in human milk. Therefore,<br />breastfeeding is not recommended during administration of bisoprolol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In a study with coronary heart disease patients bisoprolol did not impair driving<br />performance. However, due to individual variations in reactions to the drug, the ability to<br />drive a vehicle or to operate machinery may be impaired. This should be considered<br />particularly at start of treatment and upon change of medication as well as in conjunction<br />with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following definitions apply to the frequency terminology used hereafter:<br />Very common ( 1/10)<br />Common ( 1/100, &lt; 1/10)<br />Uncommon ( 1/1,000, &lt; 1/100)<br />Rare ( 1/10,000, &lt; 1/1,000)<br />Very rare (&lt; 1/10,000)<br />Psychiatric disorders:<br />Uncommon: sleep disorders, depression.<br />Rare: nightmares, hallucinations.<br />Nervous system disorders:<br />Common: dizziness*, headache*<br />Rare: syncope<br />Eye disorders:<br />Rare: reduced tear flow (to be considered if the patient uses lenses).<br />Very rare: conjunctivitis.<br />Ear and labyrinth disorders:<br />Rare: hearing disorders.<br />Cardiac disorders:<br />Very common: bradycardia (in patients with chronic heart failure).<br />Common: worsening of pre-existing heart failure (in patients with chronic heart failure).<br />Uncommon: AV-conduction disturbances, worsening of pre-existing heart failure (in<br />patients with hypertension or angina pectoris); bradycardia (in patients with hypertension<br />or angina pectoris).<br />Vascular disorders:<br />Common: feeling of coldness or numbness in the extremities, hypotension especially in<br />patient with heart failure.<br />Respiratory, thoracic and mediastinal disorders:<br />Uncommon: bronchospasm in patients with bronchial asthma or a history of obstructive<br />airways disease.<br />Rare: allergic rhinitis.<br />Gastrointestinal disorders:<br />Common: gastrointestinal complaints such as nausea, vomiting, diarrhoea, constipation.<br />Hepatobiliary disorders:<br />Rare: hepatitis.<br />Skin and subcutaneous tissue disorders:<br />Rare: hypersensitivity reactions (such as itching, flush, rash).<br />Very rare: beta-blockers may provoke or worsen psoriasis or induce psoriasis-like rash,<br />alopecia.<br />Musculoskeletal and connective tissue disorders:<br />Uncommon: muscular weakness and cramps.<br />Reproductive system and breast disorders:<br />Rare: potency disorders<br />General disorders:<br />Common: asthenia (in patients with chronic heart failure), fatigue*.<br />Uncommon: asthenia (in patients with hypertension or angina pectoris)<br />Investigations:<br />Rare: increased triglycerides, increased liver enzymes (ALAT, ASAT).<br />Applies only to hypertension or angina pectoris:<br />*These symptoms especially occur at the beginning of the therapy. They are generally<br />mild and usually disappear within 1 - 2 weeks.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most common signs expected with overdose of a beta-blocker are bradycardia,<br />hypotension, bronchospasm, acute cardiac insufficiency and hypoglycaemia. There is<br />limited experience with overdose of bisoprolol, only a few cases of overdose with<br />bisoprolol have been reported. Bradycardia and/or hypotension were noted. All patients<br />recovered. There is a wide inter-individual variation in sensitivity to one single high dose<br />of bisoprolol and patients with heart failure are probably very sensitive.<br />In general, if overdose occurs, discontinuation of bisoprolol treatment and supportive and<br />symptomatic treatment is recommended.<br />Based on the expected pharmacologic actions and recommendations for other betablockers,<br />the following general measures may be considered when clinically warranted.<br />Bradycardia: Administer intravenous atropine. If the response is inadequate, isoprenaline<br />or another agent with positive chronotropic properties may be given cautiously. Under<br />some circumstances, transvenous pacemaker insertion may be necessary.<br />Hypotension: Intravenous fluids and vasopressors should be administered. Intravenous<br />glucagon may be useful.<br />AV block (second or third degree): Patients should be carefully monitored and treated<br />with isoprenaline infusion or temporary pacing.<br />Acute worsening of heart failure: Administer i.v. diuretics, inotropic agents, vasodilating<br />agents.<br />Bronchospasm: Administer bronchodilator therapy such as isoprenaline, beta2-<br />sympathomimetic drugs and/or aminophylline.<br />Hypoglycaemia: Administer i.v. glucose.<br />Limited data suggest that bisoprolol is hardly dialysable.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Beta blocking agents, selective<br />ATC Code: C07AB07<br />Cardex is a potent highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic<br />stimulating and without relevant membrane stabilising activity. It only shows low affinity<br />to the beta2-receptor of the smooth muscles of bronchi and vessels as well as to the beta2-<br />receptors concerned with metabolic regulation. Therefore, bisoprolol is generally not to<br />be expected to influence the airway resistance and beta2-mediated metabolic effects. Its<br />beta1-selectivity extends beyond the therapeutic dose range.<br />Chronic heart failure:<br />In total 2647 patients were included in the CIBIS II trial. 83% (n = 2202) were in NYHA<br />class III and 17% (n = 445) were in NYHA class IV. They had stable symptomatic<br />systolic heart failure (ejection fraction 35%, based on echocardiography). Total<br />mortality was reduced from 17.3% to 11.8% (relative reduction 34%). A decrease in<br />sudden death (3.6% vs 6.3%, relative reduction 44%) and a reduced number of heart<br />failure episodes requiring hospital admission (12% vs 17.6%, relative reduction 36%)<br />was observed. Finally, a significant improvement of the functional status according to<br />NYHA classification has been shown. During the initiation and titration of bisoprolol<br />hospital admission due to bradycardia (0.53%), hypotension (0.23%), and acute<br />decompensation (4.97%) were observed, but they were not more frequent than in the<br />placebo-group (0%, 0.3% and 6.74%). The numbers of fatal and disabling strokes during<br />the total study period were 20 in the bisoprolol group and 15 in the placebo group.<br />The CIBIS III trial investigated 1010 patients aged 65 years with mild to moderate<br />chronic heart failure (CHF; NYHA class II or III) and left ventricular ejection fraction<br />35%, who had not been treated previously with ACE inhibitors, beta-blockers, or<br />angiotensin receptor blockers. Patients were treated with a combination of bisoprolol and<br />enalapril for 6 to 24 months after an initial 6 months treatment with either bisoprolol or<br />enalapril.<br />There was a trend toward higher frequency of chronic heart failure worsening when<br />bisoprolol was used as the initial 6 months treatment. Non inferiority of bisoprolol-first<br />versus enalapril-first treatment was not proven in the per-protocol analysis, although the<br />two strategies for initiation of CHF treatment showed a similar rate of the primary<br />combined endpoint death and hospitalization at study end (32.4% in the bisoprolol-first<br />group vs. 33.1 % in the enalapril-first group, per-protocol population). The study shows<br />that bisoprolol can also be used in elderly chronic heart failure patients with mild to<br />moderate disease.<br />Hypertension or angina pectoris:<br />Bisoprolol is used for the treatment of hypertension and angina pectoris. As with other<br />Beta- 1-blocking agents, the method of acting in hypertension is unclear. However, it is<br />known that Bisoprolol reduces plasma renin activity markedly.<br />Antianginal mechanism: Bisoprolol by inhibiting the cardiac beta receptors inhibits the<br />response given to sympathetic activation. That results in the decrease of heart rate and<br />contractility this way decreasing the oxygen demand of the cardiac muscle.<br />In acute administration in patients with coronary heart disease without chronic heart<br />failure bisoprolol reduces the heart rate and stroke volume and thus the cardiac output<br />and oxygen consumption. In chronic administration the initially elevated peripheral<br />resistance decreases.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Bisoprolol is absorbed almost completely from the gastrointestinal tract. Together with<br />the very small first pass effect in the liver, this results in a high bioavailability of<br />approximately 90%. The plasma protein binding of bisoprolol is about 30 %. The<br />distribution volume is 3.5 l/kg. The total clearance is approximately 15 l/h.<br />The plasma elimination half-life (10-12 hours) provides 24 hours efficacy following a<br />once daily dosage.<br />Bisoprolol is excreted from the body by two routes, 50 % is metabolised by the liver to<br />inactive metabolites which are then excreted by the kidneys. The remaining 50 % is<br />excreted by the kidneys in an unmetabolised form. Since elimination takes place in the<br />kidneys and the liver to the same extent a dosage adjustment is not required for patients<br />with impaired liver function or renal insufficiency.<br />In patients with chronic heart failure (NYHA stage III) the plasma levels of bisoprolol are<br />higher and the half life is prolonged compared to healthy volunteers. Maximum plasma<br />concentration at steady state is 64&plusmn;21 ng/ml at a daily dose of 10 mg and the half life is<br />17&plusmn;5 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data reveal no special hazard for humans based on conventional studies of<br />safety pharmacology, repeated dose toxicity, genotoxicity or carcinogenicity..<br />Like other beta-blockers, bisoprolol caused maternal (decreased food intake and<br />decreased body weight) and embryo/fetal toxicity (increased incidence of resorptions,<br />reduced birth weight of the offspring, retarded physical development) at high doses but<br />was not teratogenic.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline Cellulose<br />Starch<br />Talc<br />Colloidal Silicone Dioxide<br />Magnesium Stearate<br />Opadry<br />Simethicone Emulsion<br />Ferric Oxide Yellow</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30 &deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Three Aluminum-PVC/PVDC blisters of 10 film coated tablets each, packed in a printed<br />carton with folded leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.<br />Any unused product or waste material should be disposed of in accordance with local<br />requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Acino Pharma AG, Birsweg 2, 4253 Liesberg, Switzerland.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                August 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>